Filing Details

Accession Number:
0001213900-21-039168
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-07-28 21:46:08
Reporting Period:
2021-07-26
Accepted Time:
2021-07-28 21:46:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1739174 Biomx Inc. PHGE Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1761120 Gbolahan Amusa C/O Chardan Capital Markets Llc
17 State Street, 21 Floor
New York NY 10004
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0001 Acquisiton 2021-07-26 25,000 $0.00 262,871 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrants to purchase Common Stock Acquisiton 2021-07-26 18,750 $0.00 18,750 $5.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
18,750 2022-10-28 2027-01-28 No 4 P Direct
Footnotes
  1. The reporting person acquired 25,000 units consisting of one share of common stock and three-quarters of one warrant at a purchase price of $4.00 per unit.